High Dose Rate Brachytherapy as a Boost after Preoperative Chemoradiotherapy for More Advanced Rectal Tumours — the Clatterbridge Experience

This publication has 15 references indexed in Scilit:

• Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study
  Journal of Clinical Oncology, 2006
• Radiotherapy plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer: A phase I/II study
  Journal of Clinical Oncology, 2006
• Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
  Journal of Clinical Oncology, 2005
• Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathological complete response, local recurrence free survival &disease free survival
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Improved Sphincter Preservation in Low Rectal Cancer With High-Dose Preoperative Radiotherapy: The Lyon R96-02 Randomized Trial
  Journal of Clinical Oncology, 2004
• The effectiveness of preoperative intraluminal brachytherapy in preventing wall penetration and nodal involvement of rectal carcinomas.
  Surgery Today, 2000
• Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Results of preoperative intraluminal brachytherapy combined with radical surgery for middle and lower rectal carcinomas
  Journal of Surgical Oncology, 1997
• Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
  Cancer, 1994
• Present status of radiation therapy in the conservative management of rectal cancer
  Radiotherapy and Oncology, 1990